Janney Montgomery Scott (“Janney”) served as the exclusive financial advisor to AlphaGroup Medical Communications (“AlphaGroup”) in its sale to Red Nucleus.
AlphaGroup is renowned for delivering leading scientific, medical affairs, and outcomes communication services for the pharmaceutical, biotech, and medical device/diagnostic industries. The Company’s services are high-science, with over half of its employees awarded advanced scientific degrees. AlphaGroup has expansive therapeutic expertise in oncology, virology, transplantation, immunology, rare diseases, gene therapy, and cardiology.
Stephen Douthwaite, founder of AlphaGroup said, “The Janney team provided us with expert guidance throughout the journey and I am thrilled for AlphaGroup to be joining with Red Nucleus.”
AlphaGroup, founded in 2005, provides a focused set of scientific and medical communications solutions centered on key medical activities throughout a product’s lifecycle, beginning in pre-clinical development and spanning through FDA approval, product launch and continued marketing efforts. The Company brings expertise in the areas of scientific medical communications, medical affairs communications, and health economics and outcomes research (HEOR), real world evidence (RWE), and payer communications. For more information on AlphaGroup, visit www.alphagroupmedcomm.com.
About Red Nucleus
Red Nucleus is a premier provider of strategic learning and development, scientific services and advisory, medical communications solutions, and market access and commercialization services exclusively for the life sciences industry. For more information on Red Nucleus, visit www.rednucleus.com.